The Isodiol management team is made up of passionate individual’s committed to providing natural cannabinoids to the global market. The combined team has a wealth of corporate and business experience, bio-technologies, business and product development.
Marcos Agramont
Chief Executive Officer
Andrew S. Alvis
President, Director,
Chairman of Audit Committee and Interim CFO
Marvin Washington
Vice President, Director of
Business Development
Leonardo Matesanz
Director
Eli Dusenbury
Chief Financial Officer
Isodiol Shareholders
The Heart of Our Mission
At Isodiol, we understand that our shareholders are the heart and soul of our global mission. It’s through each and every shareholder that we are empowered to help people live better lives around the world.
When you invest in Isodiol, you are not simply investing in a company; you are investing in research, education, worldwide growth, and in Isodiol’s mission to bring the world’s best CBD to every person, in every corner of the globe.
May 13, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), today announces the addition of its current President, …
April 3, 2020 – Vancouver, BC – Isodiol International Inc.(CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce a shareholder …
April 1, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that …
March 3, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the“Company” or “Isodiol”), announces that it has filed itsconsolidated …
Isodiol continues to broaden its distribution in the Food, Drug and Mass (FDM) retail channel. Oct 9, 2019 – Vancouver, BC – Isodiol International Inc. …
Oct 3, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that Pawceuticals, the CBD-based …